Biomarkers in cerebrospinal fluid (CSF), such as amyloid-beta (Aβ), total tau (t-tau), and phosphorylated tau (p-tau), have been established as correlates of AD pathophysiology[6]. This evidence concerns the gene MAPT and Alzheimer disease.